Omar H Butt Selected Research

Omar H Butt Research Topics

8	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2021
6	Neoplasms (Cancer) 09/2023 - 01/2022
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 06/2023 - 01/2022
2	COVID-19 04/2023 - 07/2022
2	Infections 04/2023 - 07/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2023 - 07/2022
2	Leber Congenital Amaurosis 01/2017 - 12/2014
1	Cicatrix (Scar) 06/2023
1	Down Syndrome (Down's Syndrome) 01/2023
1	cell-associated neurotoxicity 01/2023
1	Central Nervous System Diseases (CNS Diseases) 11/2022
1	Glioma (Gliomas) 05/2022
1	Central Nervous System Neoplasms 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Amyloidosis 01/2022
1	Tauopathies 01/2022
1	Blindness (Hysterical Blindness) 01/2017

7	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2021
3	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2021
2	CytokinesIBA 04/2023 - 07/2022
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 07/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2017 - 12/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022
1	Methotrexate (Mexate)FDA LinkGeneric 11/2022
1	Vincristine (Oncovin)FDA LinkGeneric 11/2022
1	Temozolomide (Temodar)FDA LinkGeneric 05/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	NucleotidesIBA 01/2022
1	NeurograninIBA 01/2021
1	Synaptosomal-Associated Protein 25IBA 01/2021